The European Union’s medicines regulator said on Monday it will give region-wide recommendations for the COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics in the “shortest possible” time-frame.
The European Medicines Agency (EMA) said it was reviewing the available data as the watchdog seeks to help member states before possible approval.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)
